Novel brain-penetrant inhibitor of G9a methylase blocks Alzheimer’s disease proteopathology for precision medication
Ling Xie, Ryan N. Sheehy, Yan Xiong, Adil Muneer, John A. Wrobel, Kwang-Su Park, Julia Velez, Jing Liu, Yan-Jia Luo, Ya-Dong Li, Luis Quintanilla, Yongyi Li, Chongchong Xu, Mohanish Deshmukh, Zhexing Wen, Jian Jin, Juan Song, Xian Chen
doi: https://doi.org/10.1101/2023.10.25.23297491
Ling Xie
1Department of Biochemistry & Biophysics, University of North Carolina at Chapel Hill; Chapel Hill, NC 27599, USA
Ryan N. Sheehy
3Department of Pharmacology, University of North Carolina at Chapel Hill; Chapel Hill, NC 27599, USA
Yan Xiong
5Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences and Oncological Sciences, Tisch Cancer, Institute, Icahn School of Medicine at Mount Sinai; New York, NY 10029, USA
Adil Muneer
1Department of Biochemistry & Biophysics, University of North Carolina at Chapel Hill; Chapel Hill, NC 27599, USA
John A. Wrobel
1Department of Biochemistry & Biophysics, University of North Carolina at Chapel Hill; Chapel Hill, NC 27599, USA
Kwang-Su Park
5Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences and Oncological Sciences, Tisch Cancer, Institute, Icahn School of Medicine at Mount Sinai; New York, NY 10029, USA
Julia Velez
5Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences and Oncological Sciences, Tisch Cancer, Institute, Icahn School of Medicine at Mount Sinai; New York, NY 10029, USA
Jing Liu
5Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences and Oncological Sciences, Tisch Cancer, Institute, Icahn School of Medicine at Mount Sinai; New York, NY 10029, USA
Yan-Jia Luo
3Department of Pharmacology, University of North Carolina at Chapel Hill; Chapel Hill, NC 27599, USA
4Neuroscience Center, University of North Carolina at Chapel Hill; Chapel Hill, NC 27599, USA
Ya-Dong Li
3Department of Pharmacology, University of North Carolina at Chapel Hill; Chapel Hill, NC 27599, USA
4Neuroscience Center, University of North Carolina at Chapel Hill; Chapel Hill, NC 27599, USA
Luis Quintanilla
3Department of Pharmacology, University of North Carolina at Chapel Hill; Chapel Hill, NC 27599, USA
4Neuroscience Center, University of North Carolina at Chapel Hill; Chapel Hill, NC 27599, USA
Yongyi Li
3Department of Pharmacology, University of North Carolina at Chapel Hill; Chapel Hill, NC 27599, USA
Chongchong Xu
6Departments of Psychiatry and Behavioral Sciences, Cell Biology, and Neurology, Emory University School of Medicine; Atlanta, GA 30322, USA
Mohanish Deshmukh
4Neuroscience Center, University of North Carolina at Chapel Hill; Chapel Hill, NC 27599, USA
7Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill; Chapel Hill, NC 27599, USA
Zhexing Wen
6Departments of Psychiatry and Behavioral Sciences, Cell Biology, and Neurology, Emory University School of Medicine; Atlanta, GA 30322, USA
Jian Jin
5Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences and Oncological Sciences, Tisch Cancer, Institute, Icahn School of Medicine at Mount Sinai; New York, NY 10029, USA
Juan Song
3Department of Pharmacology, University of North Carolina at Chapel Hill; Chapel Hill, NC 27599, USA
4Neuroscience Center, University of North Carolina at Chapel Hill; Chapel Hill, NC 27599, USA
Xian Chen
1Department of Biochemistry & Biophysics, University of North Carolina at Chapel Hill; Chapel Hill, NC 27599, USA
2Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill; Chapel Hill, NC 27599, USA
Data Availability
All data produced in the present work are contained in the manuscript
Posted October 26, 2023.
Novel brain-penetrant inhibitor of G9a methylase blocks Alzheimer’s disease proteopathology for precision medication
Ling Xie, Ryan N. Sheehy, Yan Xiong, Adil Muneer, John A. Wrobel, Kwang-Su Park, Julia Velez, Jing Liu, Yan-Jia Luo, Ya-Dong Li, Luis Quintanilla, Yongyi Li, Chongchong Xu, Mohanish Deshmukh, Zhexing Wen, Jian Jin, Juan Song, Xian Chen
medRxiv 2023.10.25.23297491; doi: https://doi.org/10.1101/2023.10.25.23297491
Novel brain-penetrant inhibitor of G9a methylase blocks Alzheimer’s disease proteopathology for precision medication
Ling Xie, Ryan N. Sheehy, Yan Xiong, Adil Muneer, John A. Wrobel, Kwang-Su Park, Julia Velez, Jing Liu, Yan-Jia Luo, Ya-Dong Li, Luis Quintanilla, Yongyi Li, Chongchong Xu, Mohanish Deshmukh, Zhexing Wen, Jian Jin, Juan Song, Xian Chen
medRxiv 2023.10.25.23297491; doi: https://doi.org/10.1101/2023.10.25.23297491
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (718)
- Anesthesia (210)
- Cardiovascular Medicine (2995)
- Dermatology (254)
- Emergency Medicine (447)
- Epidemiology (12891)
- Forensic Medicine (12)
- Gastroenterology (840)
- Genetic and Genomic Medicine (4684)
- Geriatric Medicine (431)
- Health Economics (738)
- Health Informatics (2980)
- Health Policy (1081)
- Hematology (396)
- HIV/AIDS (942)
- Medical Education (437)
- Medical Ethics (116)
- Nephrology (479)
- Neurology (4472)
- Nursing (239)
- Nutrition (656)
- Oncology (2322)
- Ophthalmology (659)
- Orthopedics (261)
- Otolaryngology (330)
- Pain Medicine (289)
- Palliative Medicine (85)
- Pathology (506)
- Pediatrics (1212)
- Primary Care Research (509)
- Public and Global Health (7060)
- Radiology and Imaging (1570)
- Respiratory Medicine (930)
- Rheumatology (448)
- Sports Medicine (389)
- Surgery (495)
- Toxicology (61)
- Transplantation (214)
- Urology (186)